Cargando…
γδ T Cell-Mediated Antibody-Dependent Cellular Cytotoxicity with CD19 Antibodies Assessed by an Impedance-Based Label-Free Real-Time Cytotoxicity Assay
γδ T cells are not MHC restricted, elicit cytotoxicity against various malignancies, are present in early post-transplant phases in novel stem cell transplantation strategies and have been shown to mediate antibody-dependent cellular cytotoxicity (ADCC) with monoclonal antibodies (mAbs). These featu...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4251440/ https://www.ncbi.nlm.nih.gov/pubmed/25520723 http://dx.doi.org/10.3389/fimmu.2014.00618 |
_version_ | 1782347058074615808 |
---|---|
author | Seidel, Ursula Jördis Eva Vogt, Fabian Grosse-Hovest, Ludger Jung, Gundram Handgretinger, Rupert Lang, Peter |
author_facet | Seidel, Ursula Jördis Eva Vogt, Fabian Grosse-Hovest, Ludger Jung, Gundram Handgretinger, Rupert Lang, Peter |
author_sort | Seidel, Ursula Jördis Eva |
collection | PubMed |
description | γδ T cells are not MHC restricted, elicit cytotoxicity against various malignancies, are present in early post-transplant phases in novel stem cell transplantation strategies and have been shown to mediate antibody-dependent cellular cytotoxicity (ADCC) with monoclonal antibodies (mAbs). These features make γδ T cells promising effector cells for antibody-based immunotherapy in pediatric patients with B-lineage acute lymphoblastic leukemia (ALL). To evaluate combination of human γδ T cells with CD19 antibodies for immunotherapy of B-lineage ALL, γδ T cells were expanded after a GMP-compliant protocol and ADCC of both primary and expanded γδ T cells with an Fc-optimized CD19 antibody (4G7SDIE) and a bi-specific antibody with the specificities CD19 and CD16 (N19-C16) was evaluated in CD107a-degranulation assays and intracellular cytokine staining. CD107a, TNFα, and IFNγ expression of primary γδ T cells were significantly increased and correlated with CD16-expression of γδ T cells. γδ T cells highly expressed CD107a after expansion and no further increased expression by 4G7SDIE and N19-C16 was measured. Cytotoxicity of purified expanded γδ T cells targeting CD19-expressing cells was assessed in both europium-TDA release and in an impedance-based label-free method (using the xCELLigence system) measuring γδ T cell lysis in real-time. Albeit in the 2 h end-point europium-TDA release assay no increased lysis was observed, in real-time xCELLigence assays both significant antibody-independent cytotoxicity and ADCC of γδ T cells were observed. The xCELLigence system outperformed the end-point europium-TDA release assay in sensitivity and allows drawing of conclusions to lysis kinetics of γδ T cells over prolonged periods of time periods. Combination of CD19 antibodies with primary as well as expanded γδ T cells exhibits a promising approach, which may enhance clinical outcome of patients with pediatric B-lineage ALL and requires clinical evaluation. |
format | Online Article Text |
id | pubmed-4251440 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-42514402014-12-17 γδ T Cell-Mediated Antibody-Dependent Cellular Cytotoxicity with CD19 Antibodies Assessed by an Impedance-Based Label-Free Real-Time Cytotoxicity Assay Seidel, Ursula Jördis Eva Vogt, Fabian Grosse-Hovest, Ludger Jung, Gundram Handgretinger, Rupert Lang, Peter Front Immunol Immunology γδ T cells are not MHC restricted, elicit cytotoxicity against various malignancies, are present in early post-transplant phases in novel stem cell transplantation strategies and have been shown to mediate antibody-dependent cellular cytotoxicity (ADCC) with monoclonal antibodies (mAbs). These features make γδ T cells promising effector cells for antibody-based immunotherapy in pediatric patients with B-lineage acute lymphoblastic leukemia (ALL). To evaluate combination of human γδ T cells with CD19 antibodies for immunotherapy of B-lineage ALL, γδ T cells were expanded after a GMP-compliant protocol and ADCC of both primary and expanded γδ T cells with an Fc-optimized CD19 antibody (4G7SDIE) and a bi-specific antibody with the specificities CD19 and CD16 (N19-C16) was evaluated in CD107a-degranulation assays and intracellular cytokine staining. CD107a, TNFα, and IFNγ expression of primary γδ T cells were significantly increased and correlated with CD16-expression of γδ T cells. γδ T cells highly expressed CD107a after expansion and no further increased expression by 4G7SDIE and N19-C16 was measured. Cytotoxicity of purified expanded γδ T cells targeting CD19-expressing cells was assessed in both europium-TDA release and in an impedance-based label-free method (using the xCELLigence system) measuring γδ T cell lysis in real-time. Albeit in the 2 h end-point europium-TDA release assay no increased lysis was observed, in real-time xCELLigence assays both significant antibody-independent cytotoxicity and ADCC of γδ T cells were observed. The xCELLigence system outperformed the end-point europium-TDA release assay in sensitivity and allows drawing of conclusions to lysis kinetics of γδ T cells over prolonged periods of time periods. Combination of CD19 antibodies with primary as well as expanded γδ T cells exhibits a promising approach, which may enhance clinical outcome of patients with pediatric B-lineage ALL and requires clinical evaluation. Frontiers Media S.A. 2014-12-02 /pmc/articles/PMC4251440/ /pubmed/25520723 http://dx.doi.org/10.3389/fimmu.2014.00618 Text en Copyright © 2014 Seidel, Vogt, Grosse-Hovest, Jung, Handgretinger and Lang. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Seidel, Ursula Jördis Eva Vogt, Fabian Grosse-Hovest, Ludger Jung, Gundram Handgretinger, Rupert Lang, Peter γδ T Cell-Mediated Antibody-Dependent Cellular Cytotoxicity with CD19 Antibodies Assessed by an Impedance-Based Label-Free Real-Time Cytotoxicity Assay |
title | γδ T Cell-Mediated Antibody-Dependent Cellular Cytotoxicity with CD19 Antibodies Assessed by an Impedance-Based Label-Free Real-Time Cytotoxicity Assay |
title_full | γδ T Cell-Mediated Antibody-Dependent Cellular Cytotoxicity with CD19 Antibodies Assessed by an Impedance-Based Label-Free Real-Time Cytotoxicity Assay |
title_fullStr | γδ T Cell-Mediated Antibody-Dependent Cellular Cytotoxicity with CD19 Antibodies Assessed by an Impedance-Based Label-Free Real-Time Cytotoxicity Assay |
title_full_unstemmed | γδ T Cell-Mediated Antibody-Dependent Cellular Cytotoxicity with CD19 Antibodies Assessed by an Impedance-Based Label-Free Real-Time Cytotoxicity Assay |
title_short | γδ T Cell-Mediated Antibody-Dependent Cellular Cytotoxicity with CD19 Antibodies Assessed by an Impedance-Based Label-Free Real-Time Cytotoxicity Assay |
title_sort | γδ t cell-mediated antibody-dependent cellular cytotoxicity with cd19 antibodies assessed by an impedance-based label-free real-time cytotoxicity assay |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4251440/ https://www.ncbi.nlm.nih.gov/pubmed/25520723 http://dx.doi.org/10.3389/fimmu.2014.00618 |
work_keys_str_mv | AT seidelursulajordiseva gdtcellmediatedantibodydependentcellularcytotoxicitywithcd19antibodiesassessedbyanimpedancebasedlabelfreerealtimecytotoxicityassay AT vogtfabian gdtcellmediatedantibodydependentcellularcytotoxicitywithcd19antibodiesassessedbyanimpedancebasedlabelfreerealtimecytotoxicityassay AT grossehovestludger gdtcellmediatedantibodydependentcellularcytotoxicitywithcd19antibodiesassessedbyanimpedancebasedlabelfreerealtimecytotoxicityassay AT junggundram gdtcellmediatedantibodydependentcellularcytotoxicitywithcd19antibodiesassessedbyanimpedancebasedlabelfreerealtimecytotoxicityassay AT handgretingerrupert gdtcellmediatedantibodydependentcellularcytotoxicitywithcd19antibodiesassessedbyanimpedancebasedlabelfreerealtimecytotoxicityassay AT langpeter gdtcellmediatedantibodydependentcellularcytotoxicitywithcd19antibodiesassessedbyanimpedancebasedlabelfreerealtimecytotoxicityassay |